Skip to main content
. 2022 Feb 5;16(2):102424. doi: 10.1016/j.dsx.2022.102424

Fig. 1.

Fig. 1

GMT of anti-spike antibody over 6-months in all participants, SARS-CoV-2 infection naive cohorts, cohorts having past history of COVID-19 and cohorts with breakthrough infection.